Home › Funds › BOONE CAPITAL MANAGEMENT LLC › MIRM
BOONE CAPITAL MANAGEMENT LLC position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
BOONE CAPITAL MANAGEMENT LLC reported holding 415,641 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$48.7M, representing 11.38% of its reported portfolio and ranking #2 among its reported holdings. BOONE CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BOONE CAPITAL MANAGEMENT LLC's MIRM position evolved
BOONE CAPITAL MANAGEMENT LLC first disclosed a stake in MIRM in Q3 2023 at 389,791 shares (US$12.3M). The position peaked in Q2 2026 at 415,641 shares, worth US$48.7M. Across 12 filings, BOONE CAPITAL MANAGEMENT LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 415,641 shares valued at US$48.7M — a reduction of -5,595 shares quarter over quarter.. Notable position changes include a 26% increase in Q4 2023 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 389.79K | $12.32M | New |
| Q4 2023 | 490.14K | $14.47M | Add |
| Q1 2024 | 451.90K | $11.35M | Reduce |
| Q2 2024 | 523.68K | $17.90M | Add |
| Q3 2024 | 543.84K | $21.21M | Add |
| Q4 2024 | 581.84K | $24.06M | Add |
| Q1 2025 | 603.32K | $27.18M | Add |
| Q2 2025 | 641.45K | $32.64M | Add |
| Q3 2025 | 535.73K | $39.27M | Reduce |
| Q4 2025 | 421.24K | $33.27M | Reduce |
| Q1 2026 | 421.24K | $38.91M | Hold |
| Q2 2026 | 415.64K | $48.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- EMERALD ADVISERS, LLC 468.30K sh · $54.82M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K sh · $52.21M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 420.21K sh · $49.19M · Q2 2026
More on BOONE CAPITAL MANAGEMENT LLC
FAQ
How long has BOONE CAPITAL MANAGEMENT LLC held MIRM?
BOONE CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BOONE CAPITAL MANAGEMENT LLC's current position in MIRM?
As of Q2 2026, BOONE CAPITAL MANAGEMENT LLC holds 415.64K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $48.66M, representing 11.38% of its reported portfolio and ranking #2.
Has BOONE CAPITAL MANAGEMENT LLC been buying or selling MIRM?
In the latest 13F filing (Q2 2026), BOONE CAPITAL MANAGEMENT LLC reduced its position in MIRM. The position peaked in Q2 2026 at 415.64K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.